Asian shares traded lower after Fed raises rates and signals more hikes ahead.
Benchmark indices ended lower on Thursday as investors looked cautious ahead of ECB policy rate decision due later in the day after the US Federal Reserve raised interest rate by 25 basis points.
The 30-share BSE Sensex declined 139.34 points to 35,599.82 and the 50-share NSE Nifty slipped 48.70 points to 10,808.
TCS, Infosys, SBI, ICICI Bank, Axis Bank, Titan Company, Vedanta and L&T were under pressure while Lupin, Sun Pharma, Cipla and Coal India gained.
Nifty Midcap index ended flat.
Strides Shasun, Divis Labs, Wockhardt, Alembic Pharma, Torrent Pharma, Westlife Development, Jubilant Foodworks, KPIT Tech, NIIT Tech, MMTC, Dredging Corporation, Jubilant Industries, ITDC, VIP Industries, Venkys, Tata Global, Ashok Leyland gained up to 20 percent.
Mindtree, Sun TV, M&M Financial and Manappuram Finance were under pressure.
Shares of Lupin gained more than 3 percent as company received USFDA approval for pregnancy prevention tablets.
The company has received final approval for its Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg, from the USFDA (United States Food and Drug Administration).
The said tablets are the generic equivalent of Bayer’s Beyaz Tablets and indicated for use by women to prevent pregnancy, to treat symptoms of premenstrual dysphoric disorder (PMDD) for women who choose to use an oral contraceptive for contraception.